These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

371 related articles for article (PubMed ID: 30314565)

  • 1. Opioid modulation of cognitive impairment in depression.
    Jacobson ML; Wulf HA; Browne CA; Lucki I
    Prog Brain Res; 2018; 239():1-48. PubMed ID: 30314565
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Opioid system modulation of cognitive affective bias: implications for the treatment of mood disorders.
    Varastehmoradi B; Wegener G; Sanchez C; Smith KL
    Behav Pharmacol; 2020 Apr; 31(2&3):122-135. PubMed ID: 32168024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. "Top-Down" Mu-Opioid System Function in Humans: Mu-Opioid Receptors in Ventrolateral Prefrontal Cortex Mediate the Relationship Between Hedonic Tone and Executive Function in Major Depressive Disorder.
    Light SN; Bieliauskas LA; Zubieta JK
    J Neuropsychiatry Clin Neurosci; 2017; 29(4):357-364. PubMed ID: 28412878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel Targets to Treat Depression: Opioid-Based Therapeutics.
    Browne CA; Jacobson ML; Lucki I
    Harv Rev Psychiatry; 2020; 28(1):40-59. PubMed ID: 31913981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cognitive deficits in bipolar disorders: Implications for emotion.
    Lima IMM; Peckham AD; Johnson SL
    Clin Psychol Rev; 2018 Feb; 59():126-136. PubMed ID: 29195773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opiates as antidepressants.
    Berrocoso E; Sánchez-Blázquez P; Garzón J; Mico JA
    Curr Pharm Des; 2009; 15(14):1612-22. PubMed ID: 19442177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The depression-executive dysfunction (DED) syndrome and response to antidepressants: a meta-analytic review.
    McLennan SN; Mathias JL
    Int J Geriatr Psychiatry; 2010 Oct; 25(10):933-44. PubMed ID: 20872927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cognitive impairment after depression leads to disability].
    Elliott AF; Hell MD; Sheldrick-Michel A; Nielsen B
    Ugeskr Laeger; 2016 Nov; 178(45):. PubMed ID: 27855769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The cognitive effects of opioids.
    Ersek M; Cherrier MM; Overman SS; Irving GA
    Pain Manag Nurs; 2004 Jun; 5(2):75-93. PubMed ID: 15297954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of cognitive impairment in psychosocial functioning in remitted depression.
    Knight MJ; Air T; Baune BT
    J Affect Disord; 2018 Aug; 235():129-134. PubMed ID: 29655074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of opioid medications on cognitive skills among Emergency Department patients.
    Marco CA; Mann D; Rasp J; Ballester M; Perkins O; Holbrook MB; Rako K
    Am J Emerg Med; 2018 Jun; 36(6):1009-1013. PubMed ID: 29137902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of cognitive challenges in major depression: the role of the primary care physician.
    Mattingly G; Anderson RH; Mattingly SG; Anderson EQ
    Postgrad Med; 2016 Sep; 128(7):665-71. PubMed ID: 27500820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mixed κ/μ partial opioid agonists as potential treatments for cocaine dependence.
    Bidlack JM
    Adv Pharmacol; 2014; 69():387-418. PubMed ID: 24484983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frontal cortex dysfunction as a target for remediation in opiate use disorder: Role in cognitive dysfunction and disordered reward systems.
    Roberts D; Wolfarth A; Sanchez C; Pehrson AL
    Prog Brain Res; 2018; 239():179-227. PubMed ID: 30314567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cognitive-functional relationships in major depressive disorder: Crucial data from a Ukrainian open-label study of vortioxetine versus escitalopram.
    Levada OA; Troyan AS
    J Affect Disord; 2019 May; 250():114-122. PubMed ID: 30852363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cognitive control, reward-related decision making and outcomes of late-life depression treated with an antidepressant.
    Alexopoulos GS; Manning K; Kanellopoulos D; McGovern A; Seirup JK; Banerjee S; Gunning F
    Psychol Med; 2015 Oct; 45(14):3111-20. PubMed ID: 26169527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Opioid Modulation of Neuronal Iron and Potential Contributions to NeuroHIV.
    Nash B; Irollo E; Brandimarti R; Meucci O
    Methods Mol Biol; 2021; 2201():139-162. PubMed ID: 32975796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Network Meta-Analysis Comparing Effects of Various Antidepressant Classes on the Digit Symbol Substitution Test (DSST) as a Measure of Cognitive Dysfunction in Patients with Major Depressive Disorder.
    Baune BT; Brignone M; Larsen KG
    Int J Neuropsychopharmacol; 2018 Feb; 21(2):97-107. PubMed ID: 29053849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluating subjective cognitive impairment in the adult epilepsy clinic: Effects of depression, number of antiepileptic medications, and seizure frequency.
    Feldman L; Lapin B; Busch RM; Bautista JF
    Epilepsy Behav; 2018 Apr; 81():18-24. PubMed ID: 29455082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endogenous opioid system dysregulation in depression: implications for new therapeutic approaches.
    Peciña M; Karp JF; Mathew S; Todtenkopf MS; Ehrich EW; Zubieta JK
    Mol Psychiatry; 2019 Apr; 24(4):576-587. PubMed ID: 29955162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.